Develco Pharma (Switzerland)

Recent papers from Develco Pharma (Switzerland)

1. Oral Prolonged-Release Ketamine for Treatment-Resistant DepressionJAMA Network Open · 2026
2. Antidepressant effect of ketamine unrelated to dissociation: Results from an exploratory mediation analysis of the KET01-02 studyEuropean Psychiatry · 2025
3. Functional cooperation of the hedgehog and androgen signaling pathways during developmental and repairing myelinationGlia · 2021
4. Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tabletInternational Journal of Clinical Pharmacology and Therapeutics · 2017
5. Efficacy of a new once daily hydromorphone formulation in comparison with twice daily administration in chronic pain: a randomized, double-blind, cross-over studyCurrent Medical Research and Opinion · 2016
6. Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjectsThe Journal of Clinical Pharmacology · 2015
7. Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tabletCurrent Medical Research and Opinion · 2014
8. Neurohumoral Effects of the New Orally Active Renin Inhibitor, Aliskiren, in Chronic Heart FailureEuropean Journal of Heart Failure · 2007